HIV Clinical Care

Teams from across the province share ideas to BOOST engagement in lifesaving OAT

BC-CfE’s provincial BOOST Collaborative is following on the heels of the successful Vancouver-based BOOST Collaborative. BOOST is inspired by the made-in-BC Treatment as Prevention¨ strategy and supports a Targeted Disease Elimination¨ (TDE¨ ) approach. This means using tools and strategies that have been proven through the work of the BC-CfE in curbing HIV transmissions. The TDE¨ strategy can address contagious diseases and diseases with a social contagion factor, such as substance use disorders.

Teams from across the province share ideas to BOOST engagement in lifesaving OAT Read More »

Guest Post: Antiretroviral Drug Interactions with Non-Prescription Medications

This article was originally published as a Pharmacovigilance Initiative Safety Alert by the British Columbia Centre for Excellence in HIV/Aids on June 6, 2017. Patient safety concern Drug interactions between antiretroviral drugs and other medications can result in loss of therapeutic efficacy or drug toxicity. Selected proton pump inhibitors and inhaled corticosteroids recently became available

Guest Post: Antiretroviral Drug Interactions with Non-Prescription Medications Read More »

SAFETY UPDATE: Antiretroviral drug interactions with non-prescription medications

June 2017 – Drug interactions between antiretroviral drugs and other medications can result in loss of therapeutic efficacy or drug toxicity. Selected proton pump inhibitors and inhaled corticosteroids recently became available as non-prescription products in BC. These, and other non-prescription medications, can have clinically important interactions with certain antiretroviral drugs. This bulletin summarizes clinically important

SAFETY UPDATE: Antiretroviral drug interactions with non-prescription medications Read More »

Scroll to Top